MAPK8 and nasopharyngeal carcinoma: The findings revealed that PSH promoted the expression of p-ERK1/2 and p-JNK1/2, but not p-AKT and p-p38, on NPC-039 and NPC-BM cell lines in a dose-dependent manner (Figures 4A–C).